Ionis Pharmaceuticals, Inc.
MODULATORS OF HSD17B13 EXPRESSION
Last updated:
Abstract:
Methods, compounds, and compositions useful for inhibiting HSD expression are provided. Such compounds, compositions, and methods are useful for treating, preventing, or ameliorating a disease associated with HSD 17B 13.
Status:
Application
Type:
Utility
Filling date:
20 Dec 2019
Issue date:
1 Sep 2022